![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif)
Looking Back in the Medicine Cabinet...
Douglas G. Browning, MD, ATC
Arch Fam Med. 1997;6(3):263-264.
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
MODERN MEDICINE has brought numerous advances in pharmaceutical technology, giving us numerous tools at our disposal in the treatment of musculoskeletal pain. However, I am often reminded that newer is not always better, but is usually more expensive! The ever-growing number of nonsteroidal anti-inflammatory agents on the market has given us a variety of choices in the treatment of musculoskeletal inflammation, injuries, and painful conditions.
I found the study by Labelle and Guibert1 in this issue of the ARCHIVES to be of personal interest because I have used diclofenac sodium (and numerous other nonsteroidal anti-inflammatory drugs) in the treatment of lateral epicondylitis and multiple other musculoskeletal conditions. Labelle and Guibert1 found little difference in the rate of improvement in function or strength with the addition of diclofenac to their treatment regimen and only some improvement in perceived pain, while the gastrointestinal side effects of diclofenac were clearly evident in
. . . [Full Text PDF of this Article]
Author Affiliations
Primary Care Sports Medicine Department of Family and Community Medicine Bowman Gray School of Medicine Wake Forest University Winston-Salem, NC
|